rocki
mountain
virolog
associ
conceiv
region
gather
virologist
current
scientif
data
discuss
new
idea
share
addit
suffici
time
dedic
graduat
student
interact
establish
virologist
venu
select
suffici
remov
urban
set
enhanc
attend
present
free
time
provid
explor
beauti
mountain
set
year
meet
grown
includ
signific
contribut
prion
biologist
mani
nation
intern
speaker
meet
grown
past
region
focu
still
retain
uniqu
abil
provid
forum
advanc
scienc
mentorship
profession
childcar
provid
facilit
attend
individu
young
children
outdon
kid
particip
meet
showcas
variou
culinari
skill
virologyprion
tilt
formal
poster
session
taken
togeth
annual
rocki
mountain
virolog
associ
meet
figur
continu
legaci
virolog
prion
biolog
mentorship
altitud
ft
km
select
abstract
present
jennif
n
berger
depart
immunolog
microbiolog
univers
colorado
anschutz
medic
center
aurora
co
usa
investig
viral
cyclin
murin
gammaherpesviru
impact
host
viral
gene
express
sever
gammaherpesvirus
includ
murin
model
gammaherpesviru
encod
viral
cyclin
previou
work
lab
demonstr
viral
cyclin
requir
pathogenesi
reactiv
latenc
recent
demonstr
express
lana
gene
critic
maintain
establish
latenc
dramat
decreas
latent
infect
absenc
viral
cyclin
addit
lower
level
lana
express
absenc
viral
cyclin
associ
impair
reactiv
latenc
even
though
number
percentag
infect
cell
equal
viral
cyclin
defici
latent
infect
cell
sort
lana
express
cell
defect
reactiv
abrog
suggest
latent
gene
express
prime
cell
reactiv
hypothes
viral
cyclin
coordin
gene
express
facilit
viral
reactiv
latenc
rna
sequenc
rna
flow
cytometri
demonstr
subtl
differ
host
viral
gene
express
cell
lytic
infect
wild
type
viral
cyclin
defici
virus
current
use
singl
cell
rna
sequenc
analyz
permiss
fibroblast
rest
b
cell
chang
host
viral
gene
express
follow
infect
wild
type
viral
cyclin
defici
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
coloradoanschutz
medic
campu
sonja
best
laboratori
virolog
rocki
mountain
laboratori
niaid
nih
hamilton
mt
usa
present
data
obtain
postdoctor
fellow
abhilash
chiramel
describ
new
studi
role
tripartit
motif
trim
protein
suppress
flaviviru
replic
trim
larg
famili
protein
mani
induc
type
interferon
serv
suppress
viru
infect
direct
interact
viral
protein
result
disrupt
viral
replic
primat
consequenti
inhibitor
suppress
lentiviru
replic
eg
highli
host
speci
viru
speciesspecif
fashion
limit
crossspeci
transmiss
virus
importantli
antivir
effect
thought
function
exclus
context
lentiviru
infect
research
interest
center
flavivirus
includ
signific
pathogen
emerg
human
popul
primat
eg
dengu
viru
zika
viru
yellow
fever
viru
prompt
determin
whether
could
also
function
inhibit
flaviviru
replic
surprisingli
work
reveal
new
function
potent
restrict
factor
replic
specif
flavivirus
mechan
restrict
implic
flaviviru
emerg
evolut
discuss
anim
human
studi
perform
jame
burk
depart
chemistri
biochemistri
univers
colorado
boulder
co
usa
present
studi
investig
whether
ribonucleas
l
rnase
l
regul
mrna
metabol
translat
stress
granul
assembl
mammalian
cell
doublestrand
rna
dsrna
stress
respons
dsrna
mammalian
cell
induc
express
antivir
gene
arrest
translat
reduct
translat
gener
rnaprotein
rnp
complex
term
stress
granul
sg
conserv
ribonucleoprotein
complex
thought
promot
mammalian
antivir
respons
protein
kinas
r
pkr
rnase
l
function
promot
translat
shutoff
howev
pkr
wellknown
promot
sg
assembl
via
inhibit
canon
translat
initi
mechan
rnase
l
repress
translat
whether
contribut
sg
assembl
antivir
gene
express
rnase
lmediat
translat
arrest
remain
unclear
therefor
burk
colleagu
investig
effect
rnase
l
sg
assembl
translat
respons
dsrna
studi
demonstr
rnase
l
promot
rapid
widespread
turnov
mrna
limit
sg
assembl
promot
sg
disassembl
repress
translat
earli
time
postdsrna
importantli
mrna
escap
rnase
lmediat
mrna
turnov
permit
translat
mrna
earli
time
postdsrna
translat
shutoff
primarili
driven
mrna
turnov
prior
ribosom
rna
rrna
degrad
overal
find
demonstr
rapid
rnase
ldriven
translat
inhibit
driven
mrna
turnov
limit
sg
permit
rnase
l
resist
mrna
mrna
translat
global
host
shutoff
translat
anim
human
studi
perform
molli
butler
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
explor
role
cyclindepend
kinas
regul
dengueinduc
metabol
chang
dengu
viru
denv
signific
public
health
concern
current
vaccin
avail
widespread
use
treatment
limit
support
care
denv
induc
glycolysi
infect
cell
upregul
glycolysi
like
viral
direct
mechan
increas
product
metabol
precursor
requir
particl
morphogenesi
show
denv
infect
result
upregul
express
well
select
glycolyt
gene
increas
express
increas
glycolyt
gene
express
infecti
particl
format
inhibit
activ
senexin
reduc
glycolyt
gene
express
infect
reduc
activ
affect
viral
genom
replic
reduc
infecti
particl
product
work
suggest
denvinduc
metabol
chang
regul
requir
infecti
particl
product
togeth
data
provid
evid
key
cellular
factor
denv
particl
morphogenesi
may
serv
therapeut
target
anim
human
studi
perform
randal
j
cohr
univers
colorado
school
medicin
aurora
co
usa
discuss
current
state
herp
simplex
viru
type
varicella
zoster
viru
vzv
transcript
regul
latenc
vzv
ubiquit
human
neurotrop
alphaherpesvirus
establish
latenc
trigemin
ganglia
primari
infect
primari
infect
herpesviru
gene
transcript
follow
wellorchestr
pattern
involv
immediateearli
earli
late
stage
howev
viru
gene
transcript
fundament
differ
viru
reactiv
involv
gener
deregul
transcript
control
recent
target
rna
chipseq
result
obtain
human
trigemin
ganglia
present
provid
miss
piec
latenc
puzzl
final
unit
vzv
studi
also
present
describ
cultur
system
analyz
initi
event
herpesviru
reactiv
taken
togeth
stage
set
address
mechanist
question
concern
vzv
latencyreactiv
anim
human
studi
perform
hannah
jaeger
depart
microbiolog
biotechnolog
biochemistri
univers
idaho
moscow
id
usa
present
studi
human
cytomegaloviru
hcmv
known
preval
caus
neurolog
birth
defect
rang
microcephali
sensorineur
hear
loss
elucid
benefit
hcmv
deriv
modifi
particular
cellular
mechan
effici
dispers
infect
cell
within
h
post
infect
hcmv
begin
downregul
import
compon
extracellular
matrix
ecm
secret
endotheli
cell
protein
stabil
decreas
mrna
transcript
determin
absenc
increas
dispers
hcmv
seri
transmigr
assay
util
human
umbil
vein
endotheli
cell
huvec
seed
onto
polycarbon
membran
prepar
monocyt
seed
top
huvec
monolay
total
transmigr
monocyt
measur
h
hcmv
infect
huvec
shown
increas
transmigr
rate
presum
via
ecm
modif
five
differ
treatment
huvec
rang
full
hcmv
infect
knockdown
use
test
hypothesi
downregul
increas
transmigr
preliminari
result
uninfect
monolay
yield
averag
transmigr
vs
absenc
averag
transmigr
ultim
target
may
provid
hcmv
select
advantag
exact
neg
toll
develop
fetu
project
support
univers
idaho
summer
undergradu
research
fellowship
made
possibl
undergradu
research
grant
higher
educ
research
councilidaho
state
board
educ
thank
dr
vic
defelippi
ashle
mose
vgti
help
discuss
provis
reagent
studi
anim
human
studi
perform
mari
mccarthi
tem
morrison
depart
immunolog
microbiolog
univers
colorado
school
medicin
aurora
co
usa
present
work
mechan
chikungunya
viru
infect
disabl
function
capac
drain
lymph
node
chikungunya
viru
chikv
caus
larg
outbreak
rheumatolog
diseas
result
chronic
diseas
symptom
mani
infect
individu
studi
human
anim
model
suggest
chikv
infect
persist
musculoskelet
tissu
although
mechan
unclear
pathogen
chikv
strain
persist
joint
immunocompet
mice
attenu
chikv
strain
clear
adapt
immun
morrison
lab
analyz
drain
lymph
node
dln
defin
event
lymphoid
tissu
may
contribut
chikv
persist
clearanc
infect
acut
clear
chikv
result
robust
dln
enlarg
germin
center
gc
format
contrast
dln
mice
infect
pathogen
chikv
display
architectur
disrupt
paracort
reloc
b
cell
loss
distinct
bt
border
lymphocyt
deplet
dln
pathogen
chikv
infect
associ
impair
expans
function
high
endotheli
venul
lymphocyt
deplet
disorgan
preced
infiltr
dln
myeloid
cell
earli
pathogen
chikv
infect
prevent
earli
influx
inflammatori
monocyt
neutrophil
dln
revers
deplet
dln
b
cell
manner
partial
depend
product
either
nitric
oxid
superoxid
furthermor
monocyt
deplet
improv
dln
gc
format
chikvspecif
serum
neutral
antibodi
respons
data
suggest
rapid
influx
inflammatori
monocyt
dln
trigger
pathogen
persist
strain
chikv
impair
develop
adapt
immun
respons
provid
new
insight
immunolog
mechan
facilit
chikv
persist
musculoskelet
tissu
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
colorado
school
medicin
assur
number
fund
nihniaid
daniel
michalski
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
data
demonstr
gener
accumul
zikv
sfrna
infect
compromis
rna
metabol
target
host
cell
factor
involv
multipl
pathway
zika
viru
zikv
singlestrand
posit
sens
rna
flaviviru
transmit
primarili
aed
aegypti
mosquito
gener
stabl
subgenom
flaviviru
rna
sfrna
due
stall
major
cytoplasm
exoribonucleas
knotlik
three
helix
junction
structur
locat
viral
untransl
region
utr
sfrna
decay
intermedi
accumul
high
level
infect
cell
studi
flavivirus
implic
sfrna
cytopatholog
lab
object
character
function
zikv
sfrna
gain
insight
zikv
pathogenesi
specif
focus
two
key
aspect
first
determin
impact
zikv
sfrna
gener
accumul
mrna
abund
stabil
second
identifi
host
protein
interact
zikv
sfrna
begun
evalu
role
cytopathologypathogenesi
infect
jar
cell
wt
zikv
show
signific
increas
abund
stabil
cellular
mrna
correl
sfrna
accumul
time
cours
infect
rna
pulldown
experi
reveal
translat
control
deadenylationdepend
mrna
decay
factor
bind
zikv
sfrna
addit
host
cell
rna
bind
protein
rbp
involv
mrna
translat
decay
includ
also
interact
zikv
sfrna
furthermor
mani
key
rbp
involv
rna
process
identifi
priorit
studi
thu
addit
target
sfrna
appear
interact
regulon
rbp
disrupt
cellular
mrna
decay
regul
well
rna
process
factor
effort
compromis
multipl
step
rna
metabol
promot
pathogenesi
anim
human
studi
perform
zoe
donoghu
univers
colorado
school
medicin
aurora
co
usa
discuss
data
indic
multipl
class
rna
secondari
structur
present
flavivir
nonetheless
still
serv
function
viral
infect
flavivirus
yellow
fever
dengu
west
nile
zika
gener
diseaselink
viral
noncod
rna
call
subgenom
flaviviru
rna
sfrna
sfrna
implic
varieti
interact
host
vector
infect
shown
necessari
cytopath
pathogen
sfrna
accumul
progress
cellular
exoribonucleas
block
structur
rna
element
call
rna
xrrna
locat
within
viral
genom
oper
without
protein
cofactor
directli
demonstr
xrrna
abil
produc
sfrna
exist
divers
set
flavivirus
includ
specif
insect
known
arthropod
vector
shape
chemic
probe
data
indic
xrrna
compris
two
secondari
structur
class
align
previous
report
phylogen
analysi
discoveri
implic
evolut
exoribonucleas
resist
use
xrrna
synthet
biolog
develop
target
therapi
combat
flaviviru
diseas
worldwid
anim
human
studi
perform
amber
rico
univers
school
veterinari
medicin
biomed
scienc
lincoln
ne
usa
present
work
describ
vaccinia
viru
usurp
host
cellular
gene
vaccinia
kinas
essenti
viral
protein
promot
vaccinia
infect
multipl
junctur
interact
subvert
host
cellular
pathway
elucid
mechan
interact
cellular
pathway
studi
vaccinia
replic
absenc
studi
identifi
cellular
upstream
regul
vaccinia
dna
replic
use
immunofluoresc
replic
factori
dna
replic
assay
character
replic
block
caus
andor
delet
delet
alon
affect
wildtyp
vaccinia
replic
wherea
delet
alon
delay
block
vaccinia
dna
replic
importantli
delet
result
last
vaccinia
dna
replic
block
current
data
suggest
function
phosphoryl
yet
unidentifi
substrat
rescu
vaccinia
replic
absenc
implic
phosphorylationdepend
regul
sever
cellular
process
includ
apoptosi
translat
protein
degrad
intrins
immun
previou
public
howev
despit
attempt
connect
previous
identifi
substrat
depend
phenotyp
unsuccess
present
studi
highlight
util
use
vaccinia
delet
virus
identif
interact
use
viru
character
novel
role
earli
stage
vaccinia
viral
replic
ongo
studi
aim
identifi
substrat
mechan
promot
vaccinia
replic
absenc
anim
human
studi
perform
scott
seitz
depart
immunolog
microbiolog
depart
neurolog
univers
colorado
anschutz
aurora
co
usa
explor
effect
pharmacolog
deplet
microglia
increas
mortal
flavivir
model
murin
enceph
microglia
resid
immun
cell
central
nervou
system
cn
mayb
critic
control
neuroinflammatori
respons
viral
infect
microglia
help
facilit
viral
clearanc
activ
phagocytosi
infect
materi
secret
antivir
cytokin
chemokin
mainten
blood
brain
barrier
flavivirus
repres
wide
rang
virus
caus
neurolog
diseas
role
microglia
flavivirusinduc
cn
diseas
poorli
understood
microglia
depend
colonystimul
factor
receptor
signal
surviv
use
inhibitor
signal
investig
role
microglia
respons
two
flavivir
infect
west
nile
viru
wnv
japanes
enceph
viru
jev
show
treatment
mice
deplet
major
microglia
cn
deplet
microglia
alter
cytokin
chemokin
respons
viral
infect
associ
increas
mortal
wnv
earlier
onset
diseas
increas
viral
load
within
cn
studi
studi
help
suggest
microglia
play
import
role
surviv
flavivir
induc
enceph
ii
lack
microglia
lead
increas
viral
burden
within
cn
infect
anim
iii
product
mani
chemokin
cytokin
sole
secret
microglia
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
colorado
anschutz
obaiah
dirasantha
univers
colorado
boulder
biofronti
institut
depart
molecular
cellular
development
biolog
co
usa
present
data
describ
interact
pandem
host
receptor
within
popul
captiv
owl
monkey
surfac
protein
envelop
env
mediat
interact
receptor
cell
attach
entri
lab
other
recent
demonstr
primat
molecul
incompat
pandem
group
present
major
obstacl
model
nonhuman
primat
contrast
recent
show
central
south
american
owl
monkey
encod
receptor
compat
pandem
make
owl
monkey
interest
possibl
new
anim
model
pathogenesi
transmiss
base
previou
find
polymorph
within
speci
undertak
systemat
studi
receptor
polymorph
within
anim
studi
genotyp
owl
monkey
aotu
nancymaa
identifi
numer
n
n
receptor
allel
encod
uniqu
protein
variant
gener
stabl
cell
line
express
possibl
receptor
combin
challeng
variou
form
pandem
likewis
current
screen
form
pandem
env
compat
owl
monkey
receptor
identif
owl
monkey
particular
env
support
infect
tremend
potenti
improv
abil
model
infect
nonhuman
primat
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
depart
veterinari
scienc
michal
e
keel
center
compar
medicin
research
univers
texa
md
anderson
cancer
center
emili
r
feldman
depart
molecular
cellular
development
biolog
biofronti
institut
univers
colorado
boulder
boulder
co
usa
investig
function
divers
restrict
factor
tetherin
within
captiv
popul
owl
monkey
restrict
factor
intracellular
protein
inhibit
virus
numer
stage
replic
cycl
primat
lentivirus
includ
simian
immunodefici
virus
siv
evolv
numer
countermeasur
combat
restrict
factor
howev
highli
host
specif
mani
case
ineffect
confront
new
host
speci
instanc
rhesu
macaqu
tetherin
highli
effect
block
infect
human
version
fact
macaqu
version
restrict
factor
block
replic
tetherin
problemat
vaccin
test
mainli
perform
macaqu
owl
monkey
hand
signific
interest
known
monkey
speci
encod
minim
block
infect
includ
function
entri
receptor
previou
studi
identifi
nonfunct
tetherin
allel
owl
monkey
base
undertak
systemat
studi
tetherin
polymorph
captiv
owl
monkey
speci
genotyp
tetherin
owl
monkey
aotu
nancymaa
identifi
eight
allel
encod
uniqu
protein
variant
gener
stabl
cell
line
express
tetherin
allel
challeng
variou
isol
addit
current
screen
siv
nef
gene
abil
counteract
owl
monkey
tetherin
identif
owl
monkey
defect
tetherin
allel
particular
nef
version
effici
degrad
owl
monkey
tetherin
tremend
potenti
further
owl
monkey
novel
nonhuman
primat
model
infect
anim
human
studi
perform
conor
kelli
edward
chuong
biofronti
institut
univers
colorado
boulder
boulder
co
usa
present
preliminari
data
explor
possibl
involv
speciesspecif
transpos
element
evolut
type
ii
interferon
respons
endogen
retrovirus
erv
constitut
mammalian
genom
contain
transcript
factorbound
regulatori
sequenc
function
genom
studi
implic
ancient
erv
sourc
regulatori
element
evolutionarili
coopt
regul
process
immun
develop
howev
given
erv
highli
lineagespecif
rais
question
erv
cooption
differ
speci
may
shape
biolog
differ
chuong
lab
previous
identifi
primatespecif
erv
coopt
enhanc
regul
interferoninduc
innat
immun
respons
human
cell
provid
bind
site
transcript
factor
press
question
whether
respons
mammalian
speci
also
shape
erv
cooption
investig
idea
analyz
genomewid
respons
interferon
gamma
ifng
cell
nonprim
speci
name
mous
musculu
dog
c
l
familiari
cow
b
tauru
preliminari
analysi
publish
mous
chromatin
profil
transcriptom
dataset
assay
bone
marrowderiv
macrophag
reveal
bind
event
ifng
treat
cell
site
deriv
erv
transposon
transposonderiv
site
locat
within
kilobas
interferonstimul
gene
select
candid
enhanc
deriv
erv
transposon
potenti
regul
mous
interferonstimul
test
regulatori
function
use
crisprbas
approach
mous
macrophag
cell
line
chuong
lab
preliminari
result
suggest
primat
rodent
immun
respons
undergon
evolutionari
rewir
facilit
lineagespecif
erv
anim
human
studi
perform
ashley
knox
depart
microbiolog
immunolog
univers
colorado
school
medicin
aurora
co
usa
present
data
examin
effect
viral
infect
transcript
host
viral
noncod
rna
viral
rna
known
play
vital
role
viral
infect
replic
regul
viral
rna
polymeras
iii
pol
iii
transcrib
noncod
rna
ncrna
remain
unclear
gammaherpesvirus
contain
multipl
ncrna
highli
express
infect
tmer
ncrna
requir
pathogenesi
viru
ncrna
eber
contribut
b
cell
transform
addit
sever
host
ncrna
shown
upregul
gammaherpesviru
infect
play
integr
role
pathogenesi
includ
sine
stimul
signal
ultim
increas
viral
gene
express
vault
rna
protect
b
cell
apoptosi
allow
enhanc
viral
establish
therefor
detail
ncrna
regul
integr
understand
role
pathogenesi
compar
transcript
regul
pol
iii
ncrna
clone
sever
type
pol
iii
promot
newli
gener
luciferas
report
optim
measur
pol
iii
promot
activ
infect
promot
includ
host
ncrna
rrna
trna
snrna
tmer
ebv
eber
adenoviru
va
rna
infect
drive
simultan
repress
human
promot
activ
stimul
tmer
promot
tmer
promot
induct
prevent
inhibitor
viral
protein
synthesi
indic
aspect
infect
vital
drive
transcript
regul
analysi
pol
iii
promot
activ
indic
uniqu
regul
pattern
host
viral
ncrna
identifi
critic
promot
featur
preferenti
express
infect
anim
human
studi
perform
kirsten
krieger
arthropodborn
infecti
diseas
laboratori
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
data
use
cctalpha
enzym
control
point
limit
dengu
viru
serotyp
replic
caus
million
case
dengu
fever
annual
dengu
virus
denv
aggress
arthropodborn
human
pathogen
characterist
mani
positivesens
rna
virus
share
abil
restructur
host
cell
lipid
membran
order
assembl
viral
replic
complex
virus
reorgan
host
lipid
benefit
construct
platform
replic
assembl
phosphatidylcholin
pc
amphipath
lipid
make
total
phospholipid
content
eukaryot
cellular
membran
previou
studi
differ
positivesens
rna
virus
shown
pc
accumul
viral
replic
site
cell
infect
brome
mosaic
viru
hepat
c
polioviru
shown
pc
synthesi
significantli
enhanc
denvinfect
mosquito
cell
pc
synthes
via
kennedi
pathway
pemt
pathway
pemt
pathway
common
liver
cell
produc
maximum
pc
howev
kennedi
pathway
present
nucleat
eukaryot
cell
abund
tissu
ratelimit
step
pc
synthesi
catalyz
cctalpha
enzym
sirna
knockdown
cctalpha
decreas
denv
replic
knock
cctalpha
lab
also
shown
sirna
use
cytotox
cell
lab
valid
role
enzym
hypothesi
cctalpha
use
denv
viral
replic
site
amplifi
pc
synthesi
local
thu
chang
lipid
composit
membran
benefit
viral
life
cycl
anim
human
studi
perform
elena
lian
arthropodborn
infecti
diseas
laboratori
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
preliminari
data
evalu
arachidon
acid
mediat
membran
biogenesi
dengu
virusserotyp
infect
dengu
virus
attribut
estim
million
annual
infect
endem
tropic
subtrop
region
world
virus
replic
membran
endoplasm
reticulum
er
alter
host
lipid
biosynthet
pathway
achiev
purpos
interest
arachidon
acid
aa
long
polyunsatur
fatti
acid
incorpor
cellular
membran
increas
membran
fluiditi
also
progenitor
leukotrien
act
signal
molecul
fatti
acid
desaturas
ratelimit
enzym
linol
acid
pathway
synthes
aa
metabol
intermedi
downstream
aa
catalyz
product
leukotrien
one
shown
interact
fatti
acid
synthas
fa
fa
key
enzym
de
novo
fatti
acid
synthesi
produc
long
chain
fatti
acid
also
integr
membran
lab
hypothes
aamedi
membran
biogenesi
facilit
format
viral
replic
complex
er
membran
chemic
inhibit
sirna
analys
use
lab
target
elucid
role
aa
infect
dengu
virusserotyp
preliminari
result
indic
decreas
viral
releas
either
enzym
inhibit
infect
thu
present
two
enzymat
control
limit
viral
replic
transmiss
anim
human
studi
perform
mora
gonzalez
lopez
ledesma
laboratorio
de
molecular
instituto
leloirconicet
bueno
air
argentina
assess
interact
viral
protein
dengu
viru
cellular
host
protein
extend
studi
zika
viru
infect
dengu
viru
denv
one
import
human
viral
pathogen
transmit
insect
belong
flavivirida
famili
togeth
human
pathogen
west
nile
viru
japanes
enceph
viru
zika
viru
zikv
recent
outbreak
zikv
america
link
microcephali
put
viru
forefront
intern
research
effort
understand
cellular
target
pathogenesi
flaviviru
protein
play
multipl
function
infect
enabl
viral
replic
counteract
host
antivir
respons
investig
interact
cellular
compon
perform
proteom
studi
use
tag
denv
identifi
host
protein
bind
form
complex
infect
valid
number
interact
among
binder
found
core
compon
host
spliceosom
machineri
compon
snrnp
particl
interestingli
silenc
protein
enhanc
denv
viral
replic
model
propos
bind
snrnp
protein
hijack
splice
machineri
result
less
restrict
environ
viral
replic
studi
extend
zikv
recent
observ
downregul
slightli
increas
zikv
replic
although
studi
need
summari
technolog
investig
interact
viral
infect
develop
use
defin
novel
function
viral
protein
vast
amount
inform
provid
studi
current
use
valid
interact
denv
zikv
infect
anim
human
studi
perform
carolin
montgomeri
gabi
ramirez
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
explor
dengu
virus
denv
member
flavivirida
famili
transmit
aed
aegypti
mosquito
infect
million
peopl
annual
antivir
suboptim
vaccin
avail
protect
denv
manipul
lipid
metabol
pathway
host
acquir
lipid
envelop
purpos
assembl
membran
genom
replic
immun
evas
identifi
novel
target
antivir
develop
understand
virus
hijack
host
lipid
metabol
pathway
benefit
goal
inhibit
metabol
enzym
requir
viru
replic
choke
acut
viru
infect
human
host
shown
unsatur
fatti
acid
biosynthesi
pathway
manipul
denv
fatti
acid
maintain
membran
fluiditi
incorpor
complex
lipid
stearoyl
coa
desaturas
ratelimit
enzym
homeostasi
unsatur
fatti
acid
increas
upon
infect
denv
assess
signific
enzym
downstream
denv
life
cycl
enzym
includ
acyltransferas
gpat
acylglycerolphosph
acyltransferas
agpat
diacylglycerol
acyltransferas
dgat
acylcoa
cholesterol
acyltransferas
acat
hypothes
denv
replic
reduc
inhibit
enzym
downstream
lead
lower
avail
ufa
requir
genom
replic
envelop
particl
assembl
carri
loss
function
studi
enzym
determin
impact
denv
replic
preliminari
result
present
anim
human
studi
perform
taylor
clarkson
colorado
state
univers
fort
collin
co
usa
present
data
explor
nootkaton
natur
organ
compound
grapefruit
alaskan
yellow
cedar
novel
insecticid
insect
repel
test
nootkaton
product
insecticid
repel
activ
two
promin
vector
zika
viru
zikv
aed
aegypti
aed
albopictu
test
pyrethroidresist
pyrethroidsuscept
strain
speci
determin
whether
physiolog
statu
affect
suscept
nootkaton
conduct
assay
use
uninfect
zikvinfect
mosquito
cdc
bottl
bioassay
show
pyrethroidsuscept
strain
ae
aegypti
ae
albopictu
suscept
nootkaton
pyrethroidresist
strain
assay
also
conduct
zikvinfect
mosquito
well
show
zikvinfect
mosquito
significantli
suscept
nootkaton
uninfect
control
repel
bite
inhibit
nootkaton
primari
test
treat
human
arm
use
repellencyirrit
bite
inhibit
bioassay
ribb
bioassay
three
differ
test
subject
test
variou
type
exist
repel
product
sever
concentr
nootkaton
formul
appli
one
arm
spatial
attract
index
bite
inhibit
ae
aegypti
measur
gener
conclus
discov
nootkaton
work
repel
mosquito
rate
compar
deet
picaridin
potenti
efficaci
insecticid
aed
mosquito
zikvinfect
uninfect
fund
evolva
nih
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
colorado
state
univers
daniel
hartman
colorado
state
univers
depart
microbiolog
immunolog
patholog
fort
collin
colorado
usa
present
entomolog
work
explor
risk
rift
valley
fever
viru
introduct
may
pose
feed
lot
introduc
rvfv
could
caus
signific
econom
loss
livestock
industri
addit
substanti
human
morbid
mortal
like
establish
zoonosi
littl
hope
erad
explor
potenti
transmiss
rvfv
agricultur
set
support
intens
livestock
product
kade
laboratori
investig
mosquito
commun
composit
livestock
feedlot
surround
natur
residenti
area
culex
tarsali
coquillett
mosquito
hypothes
locallyimport
bridg
vector
event
introduct
rvfv
due
abund
compet
transmiss
rvfv
season
fluctuat
blood
host
select
includ
larg
mammal
human
mosquito
trap
use
pairedsit
design
trap
place
feedlot
well
nearbi
site
determin
whether
presenc
livestock
affect
mosquito
abund
commun
composit
signific
associ
note
mosquito
speci
habitat
type
cx
tarsali
collect
feedlot
nearbi
site
divers
vertebr
blood
meal
detect
includ
cattl
data
indic
propens
cx
tarsali
feed
cattl
also
suggest
dispers
speci
feedlot
surround
area
data
support
potenti
cx
tarsali
serv
bridg
vector
rvfv
human
livestock
commun
colorado
anim
human
studi
perform
ashley
janich
along
karla
saavedrarodriguez
william
black
iv
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
investig
aspect
permethrin
resist
aed
albopictu
mosquito
southern
mexico
insecticid
resist
known
mechan
extens
studi
aed
aegypti
mosquito
major
vector
zika
dengu
chikungunya
virus
howev
anoth
import
vector
aed
albopictu
primari
method
control
spread
vector
diseas
insecticid
applic
continu
applic
insecticid
like
permethrin
ae
aegypti
develop
observ
resist
requir
increasingli
higher
concentr
kill
import
understand
ae
albopictu
also
develop
resist
possibl
mechan
involv
collect
ae
albopictu
chiapa
mx
rear
lab
expos
adult
locat
sever
concentr
permethrin
concentr
need
kill
mosquito
resist
ratio
rr
calcul
current
result
show
lower
mortal
mosquito
mexico
compar
control
rr
rang
indic
low
level
resist
predict
see
increas
rr
continu
select
survivor
offspr
result
pend
addit
sequenc
screen
dna
mosquito
surviv
permethrin
exposur
known
resist
polymorph
see
mutat
confer
resist
result
studi
help
consid
proceed
futur
method
mosquito
control
fund
nih
grant
insecticid
resist
manag
preserv
pyrethroid
aed
aegypti
anim
human
studi
perform
ami
gilbert
nation
wildlif
research
center
usda
aphi
wildlif
servic
fort
collin
co
usa
describ
epidemiolog
rabi
viru
rabv
infect
wildlif
unit
state
research
investig
recent
epizoot
southcentr
skunk
rabv
lineag
northern
colorado
southern
wyom
rabi
highli
lethal
zoonosi
rabv
circul
maintain
divers
number
bat
wild
carnivor
reservoir
north
america
lineag
circul
carnivor
caus
greater
burden
spillov
infect
anim
exposur
human
especi
rabv
circul
raccoon
procyon
lotor
stripe
skunk
mephiti
mephiti
recogn
rabv
reservoir
north
america
much
past
centuri
sever
lineag
recogn
decad
ago
still
circul
today
southcentr
skunk
scsk
lineag
one
histor
lineag
expand
geograph
rang
colorado
typic
peripheri
scsk
circul
decad
appar
absenc
lineag
reemerg
two
signific
epizoot
detect
northern
colorado
stare
studi
analyz
case
data
collect
local
public
health
depart
northern
colorado
enhanc
surveil
start
describ
spatiotempor
spread
epizoot
result
enhanc
surveil
collabor
test
effort
studi
also
opportunist
document
wild
carnivor
pathogen
infect
includ
bartonella
canin
distemp
viru
result
discuss
light
implic
human
anim
health
anim
human
studi
perform
keir
balla
depart
human
genet
univers
utah
school
medicin
salt
lake
citi
ut
usa
intend
describ
effort
develop
zebrafish
model
viru
host
switch
evolut
vertebr
immun
system
recent
largescal
genom
phylogenet
studi
reveal
host
switch
extrem
pervas
viru
famili
fact
common
maintain
host
specif
evolutionari
time
understand
virus
switch
host
specif
critic
prevent
manag
new
viral
outbreak
evolutionari
molecular
base
viru
host
switch
remain
larg
obscur
keir
propos
appli
extens
molecular
toolkit
develop
zebrafish
vaccinia
viru
research
uniqu
combin
model
system
identifi
host
viral
determin
viru
host
switch
novel
cell
cultur
wholeanim
set
poxvirus
identifi
fish
host
rang
vaccinia
viru
restrict
mammal
identifi
viru
determin
host
switch
adapt
vaccinia
viru
replic
zebrafish
parallel
character
evolut
function
vertebr
interferon
respons
zebrafish
identifi
host
determin
viru
replic
host
switch
given
constant
threat
emerg
viru
infect
work
pois
uncov
molecular
evolutionari
signatur
may
improv
abil
monitor
viral
outbreak
human
well
fish
agricultur
import
vertebr
host
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
utah
sierra
beach
depart
biolog
scienc
univers
idaho
moscow
id
usa
present
empir
data
base
comput
model
predict
point
mutat
fusion
glycoprotein
f
protein
respiratori
syncyti
viru
rsv
may
escap
monoclon
antibodi
human
rsv
second
lead
caus
infant
mortal
world
respons
death
year
current
licens
vaccin
treatment
palivizumab
prophylact
monoclon
antibodi
target
viral
f
protein
given
lack
therapeut
option
mutat
f
protein
allow
viru
escap
antibodi
neutral
high
concern
lab
seek
establish
molecular
model
predict
antibodi
escap
mutant
f
protein
molecular
dynam
simul
f
gene
perform
bind
site
motavizumab
palivizumab
deriv
predict
antibodi
escap
mutat
engin
infecti
clone
test
viabil
fit
neutral
parallel
studi
wild
type
infecti
clone
subject
select
passag
vitro
presenc
motavizumab
antibodi
compar
predict
variant
isol
select
pressur
follow
select
passag
sampl
requir
higher
antibodi
concentr
neutral
sequenc
compar
predict
mutat
one
predict
one
unpredict
f
gene
mutat
found
sampl
one
predict
mutat
found
motavizumab
sampl
result
promis
experi
need
test
limit
model
studi
seek
captur
power
predict
capabl
molecular
model
transform
clinic
relev
watchlist
potenti
new
therapeut
set
foundat
predict
mutat
import
virus
research
fund
nation
scienc
foundat
epscor
research
infrastructur
improv
program
award
number
anim
human
studi
perform
della
fixsen
eld
lab
univers
utah
depart
human
genet
salt
lake
citi
ut
usa
present
work
describ
poxvirus
acquir
host
gene
activ
retrotransposit
infect
cell
horizont
gene
transfer
hgt
provid
major
sourc
genet
variat
viru
evolut
mani
virus
encod
host
protein
diverg
gain
new
function
alter
cellular
process
subvert
host
defens
host
gene
acquisit
common
mean
viral
adapt
mechan
dynam
process
well
understood
devis
system
induc
select
hgt
event
poxviru
popul
use
vaccinia
model
mutant
virus
lack
propag
complement
cell
chromosom
integr
screen
strain
overcam
antivir
pkr
pathway
replic
noncompl
cell
recov
viru
clone
experi
strain
independ
acquir
via
hgt
complement
cell
genom
analysi
reveal
target
site
duplic
poli
tail
lack
intron
integr
construct
support
mechan
retrotranspos
viral
gene
activ
infect
cell
also
found
corrobor
evid
mediat
hgt
publish
genom
divers
virus
result
reveal
mobil
host
gene
viru
genom
might
repres
primari
mechan
viru
evolut
human
anim
studi
perform
emmanuel
ijezi
depart
biolog
scienc
center
model
complex
interact
univers
idaho
moscow
id
usa
present
rhinoviru
curtail
diseas
sever
respiratori
viral
coinfect
mice
patient
suffer
viral
respiratori
diseas
often
infect
multipl
unrel
virus
known
coinfect
howev
unclear
viral
coinfect
influenc
diseas
pathogenesi
lab
previous
establish
mous
model
respiratori
viral
coinfect
answer
question
mice
inocul
mild
respiratori
viru
rhinoviru
two
day
viru
caus
sever
diseas
influenza
viru
coinfect
reduc
sever
infect
determin
mortal
weight
loss
clinic
sign
diseas
mous
lung
collect
day
postinfect
patholog
analys
lung
tissu
paraffinembed
stain
analysi
histolog
slide
stain
masson
trichrom
stain
hematoxylin
eosin
h
e
stain
evalu
inflamm
tissu
damag
immunohistochemistri
use
show
local
viru
immun
cell
analys
show
mediat
earli
immun
respons
character
neutrophil
recruit
follow
viral
clearanc
tissu
repair
interact
viral
coinfect
still
poorli
research
result
like
import
role
elucid
mechan
necessari
reduc
sever
influenza
infect
respiratori
viral
coinfect
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
idaho
andr
rodriguez
univers
idaho
moscow
id
usa
present
data
describ
differ
viral
coinfect
singl
infect
mous
lung
epitheli
cell
patient
hospit
respiratori
infect
often
shown
infect
multipl
virus
studi
coinfect
mice
shown
differ
infect
sever
mice
singli
coinfect
littl
inform
exist
two
differ
virus
interact
share
cell
popul
whether
immun
respons
competit
inhibit
limit
growth
one
virus
studi
observ
differ
viral
titer
lung
epitheli
cell
popul
infect
singl
viru
coinfect
murin
coronaviru
rhinoviru
supernat
medium
collect
everi
six
hour
postinfect
h
determin
viral
titer
timepoint
tissu
cultur
infect
dose
assay
use
compar
viral
titer
multipl
time
point
give
insight
differ
viral
growth
coinfect
singl
infect
data
provid
insight
coinfect
behav
within
cell
popul
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
idaho
project
fund
part
nation
scienc
foundat
reu
site
award
franc
v
scholz
depart
biolog
scienc
center
model
complex
interact
univers
idaho
moscow
id
usa
studi
respiratori
syncyti
viru
rsv
intracellular
pathogen
infect
peopl
age
rsv
respons
mani
death
year
current
licens
vaccin
altern
form
therapi
monoclon
antibodi
use
treat
infect
neutral
viru
want
investig
abil
rsv
mutat
stress
human
monoclon
antibodi
hypothes
rsv
mutat
stress
subinhibitori
dose
result
escap
neutral
molecular
model
done
collabor
also
accur
predict
mutat
test
introduc
rsv
round
select
presenc
allow
time
mutat
aris
round
select
cell
viral
mutant
requir
significantli
antibodi
neutral
mutant
sequenc
specif
amino
acid
chang
compar
model
predict
done
collabor
result
help
better
understand
rsv
evolv
escap
neutral
anim
human
studi
perform
sarah
stonedahl
depart
neurolog
univers
colorado
school
medicin
aurora
co
usa
investig
role
microglia
control
viral
growth
subsequ
virusinduc
mortal
mice
infect
west
nile
viru
wnv
wnv
neurotrop
mosquitoborn
singlestrand
rna
flaviviru
eighti
percent
human
infect
asymptomat
infect
lead
acut
ill
known
west
nile
fever
less
human
infect
lead
sever
neurolog
diseas
enceph
mening
acut
flaccid
paralysi
wnv
infect
neuron
caus
cell
death
apoptosi
previou
work
lab
found
microglia
resid
inflammatori
cell
brain
becom
activ
initi
innat
immun
respons
wnv
infect
also
show
microglia
critic
wnv
cn
infect
mice
limit
viral
growth
prevent
mortal
howev
exact
mechan
microglia
protect
cn
remain
unclear
begin
investig
role
microglia
limit
viral
growth
mortal
use
vivo
mous
ex
vivo
brain
slice
culturesbsc
method
model
wnv
enceph
determin
wnv
usual
seen
brain
mice
follow
peripher
infect
day
post
infect
mice
whose
microglia
deplet
use
drug
measur
viral
titer
brain
earli
day
post
infect
also
found
use
bsc
increas
activ
bsc
treat
plx
lead
conclus
microglia
limit
amount
apoptosi
bsc
infect
wnv
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
colorado
school
medicin
joseph
westrich
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
preliminari
data
establish
immun
compet
small
anim
model
zika
viru
infect
approxim
zika
viru
zikv
infect
subclin
recent
zikv
epidem
reveal
mosquitoborn
flaviviru
caus
agent
congenit
abnorm
observ
babi
born
zikvinfect
mother
zikv
shown
cross
placent
structur
infect
fetu
even
mother
subclin
zikv
infect
remain
poorli
defin
antivir
immun
respons
elicit
presenc
zikv
interfac
impact
may
pregnanc
outcom
experiment
model
urgent
need
recapitul
human
diseas
mani
zika
pathogenesi
studi
reli
upon
use
immun
defici
mice
model
provid
extens
insight
zika
infect
unreli
character
contribut
immun
respons
zikv
transplacent
traffick
fetal
infect
potenti
lifelong
effect
offspr
previou
studi
shown
guinea
pig
immun
compet
laboratori
anim
suscept
zikv
infect
furthermor
guinea
pig
appeal
model
studi
target
investig
maternalfet
interfac
placent
structur
fetal
develop
close
resembl
human
show
preliminari
data
establish
guinea
pig
model
subclin
zikv
infect
guinea
pig
serolog
respons
zikv
preliminari
detect
viral
genom
peripher
blood
suggest
activ
infect
outwardli
infect
guinea
pig
exhibit
acut
perturb
temperatur
weight
loss
suggest
subclin
infect
immun
compet
small
anim
model
permit
character
matern
zikv
infect
diseas
progress
antivir
immun
respons
consequ
factor
fetal
offspr
develop
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
chaop
chen
depart
biochemistri
molecular
biolog
colorado
state
univers
fort
collin
co
usa
describ
hiv
proteas
inhibitor
suscept
proteas
autoprocess
correl
indic
drug
resist
proteas
autoprocess
liber
free
matur
proteas
gagpol
polyprotein
precursor
concert
virion
releas
event
hiv
proteas
inhibitor
pi
suppress
matur
proteas
activ
tight
bind
activ
site
extens
sequenc
analysi
identifi
variou
major
minor
resist
associ
mutat
ram
within
proteas
gene
recombin
matur
pr
carri
ram
normal
remain
respons
pi
suppress
correl
well
clinic
manifest
pi
resist
report
optim
evalu
cellbas
function
assay
quantif
autoprocess
effici
pi
suscept
use
alphalisa
amplifi
luminesc
proxim
homogen
assay
elisa
analyz
collect
known
proteas
inhibitor
alphalisa
assay
confirm
known
antihiv
proteas
inhibitor
librari
suppress
precursor
autoprocess
low
micromolar
proteas
inhibitor
impact
precursor
autoprocess
furthermor
autoprocess
fusion
precursor
carri
variou
ram
identifi
patient
experienc
pi
resist
exhibit
pi
respons
profil
close
match
report
pi
resist
also
found
complex
function
interplay
among
residu
insid
outsid
pr
code
sequenc
attribut
modul
autoprocess
activ
pi
suscept
contextdepend
fashion
collect
result
support
idea
regul
precursor
autoprocess
key
determin
contribut
pi
resist
develop
alphalisa
assay
provid
power
tool
identif
character
ram
contribut
pi
resist
correl
assess
autoprocess
phenotyp
clinic
prognosi
pi
respons
anim
human
studi
perform
brigett
corder
univers
nebraskalincoln
depart
biolog
scienc
lincoln
ne
usa
present
data
compar
central
gene
use
univers
influenza
vaccin
year
influenza
viru
envelop
neg
sens
singlestrand
segment
rna
viru
caus
million
case
despit
increas
use
annual
flu
vaccin
current
vaccin
method
protect
certain
strain
event
mismatch
viru
provid
limit
protect
infect
ill
reason
creat
test
univers
vaccin
induc
broad
protect
influenza
imper
propos
explor
central
gene
express
viral
vector
promis
influenza
vaccin
strategi
human
influenza
hemagglutinin
hemagglutinin
ha
surfac
protein
influenza
envelop
involv
viral
entri
sever
central
gene
strategi
test
seek
maxim
coverag
popul
genet
diverg
analyz
uniqu
sequenc
genbank
databas
consensu
ha
design
use
common
amino
acid
locat
ha
sequenc
mosaic
ha
construct
repeat
silico
recombin
event
use
bia
toward
repeat
peptid
mosaic
strategi
favor
repetit
increas
number
potenti
b
cell
epitop
recogn
ha
central
ha
gene
express
pcdna
recombin
replicationdefici
adenoviru
type
viru
recombin
vaccinia
viru
cellular
humor
immun
respons
assess
compar
wildtyp
gene
express
viral
vector
togeth
project
reveal
promis
central
antigen
express
viral
vector
univers
influenza
vaccin
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
nebraska
lincoln
teresa
ng
abbvi
inc
north
chicago
il
usa
present
overview
revolut
hepat
c
viru
therapi
chronic
hcv
infect
major
global
health
problem
estim
million
individu
infect
worldwid
date
seven
distinct
hcv
genotyp
identifi
undetect
left
untreat
chronic
hcv
infect
lead
seriou
liver
diseas
cirrhosi
liver
failur
hepatocellular
carcinoma
sustain
virolog
respons
svr
result
treatment
chronic
hcv
infect
shown
significantli
reduc
liver
diseas
progress
develop
hepatocellular
carcinoma
mortal
treatment
hcv
infect
dramat
improv
past
decad
pegyl
interferonribavirin
pegifnrbv
avail
sinc
earli
treatment
use
wide
due
variabl
efficaci
differ
hcv
genotyp
svr
rang
sever
side
effect
long
treatment
durat
week
need
administ
pegifn
subcutan
inject
first
hcv
direct
act
antivir
daa
two
differ
hcv
proteas
inhibitor
approv
sinc
number
hcv
daa
approv
includ
inhibitor
hcv
proteas
protein
polymeras
current
hcv
treatment
regimen
pegifnfre
includ
two
three
daa
target
differ
hcv
protein
without
addit
rbv
newest
hcv
daa
regimen
approv
past
year
conveni
take
daili
oral
administr
short
eight
week
pegifn
rbvfree
efficaci
patient
infect
major
hcv
genotyp
svr
exhibit
high
barrier
develop
daa
resist
avail
conveni
efficaci
treatment
revolution
effort
erad
hcv
infect
global
studi
use
human
subject
abbvi
daa
approv
respect
institut
review
board
studi
site
david
barton
univers
colorado
school
medicin
aurora
co
usa
describ
viral
rna
replic
mechan
impact
error
catastroph
asexu
templatedepend
rna
replic
mechan
effici
render
virus
suscept
error
catastroph
sexual
rna
replic
mechan
ineffici
shape
picornaviru
speci
group
counteract
error
catastroph
use
viral
rna
recombin
assay
phylogenet
sequenc
data
atom
structur
viral
polymeras
identifi
featur
polymeras
requir
sexual
rna
replic
mechan
disabl
sexual
rna
replic
mechan
polymeras
mutat
polioviru
becom
exquisit
sensit
ribavirininduc
error
catastroph
data
substanti
long
held
theori
regard
advantag
disadvantag
asexu
sexual
replic
strategi
among
rna
virus
particular
show
picornaviru
rna
recombin
counteract
neg
consequ
asexu
templatedepend
rna
replic
error
catastroph
anim
human
studi
perform
support
nih
grant
olv
peersen
colorado
state
univers
fort
collin
co
usa
present
data
chimer
picornavir
polymeras
built
use
polioviru
coxsackieviru
enzym
project
foundat
prior
structur
biolog
work
laboratori
show
conserv
polymeras
fold
analog
right
hand
compos
finger
palm
thumb
domain
presenc
uniqu
mechan
close
activ
site
catalysi
via
ntpdepend
conform
chang
palm
domain
biochem
studi
coxsackieviru
polioviru
polymeras
show
mutat
palm
domain
result
drastic
chang
fidel
elong
rate
faster
rdrp
lower
fidel
lead
hypothesi
primari
regul
rdrp
fidel
conform
chang
palm
domain
associ
activ
site
closur
explor
lab
gener
chimer
polymeras
mix
match
structur
element
pv
cv
enzym
eight
chimer
polymeras
design
swap
entir
finger
domain
pinki
finger
thumb
domain
pv
cv
result
polymeras
express
purifi
bacteria
biochem
assay
rna
bind
initi
process
elong
rate
elong
complex
stabil
nucleotid
select
addit
chimer
polymeras
insert
infecti
clone
polioviru
coxsackieviru
subset
support
viru
replic
cell
anim
human
studi
perform
work
support
nih
award
stephani
moon
depart
biochemistri
univers
colorado
boulder
co
usa
present
work
collabor
project
tim
stasevich
lab
colorado
state
univers
rnaprotein
granul
stress
granul
pbodi
form
integr
stress
respons
translat
global
suppress
type
cytoplasm
assembl
contain
divers
mrna
enrich
rna
bind
protein
stress
granul
harbor
translat
factor
pbodi
contain
mrna
decay
factor
mani
rna
virus
includ
flavivirus
eg
west
nile
viru
dengu
virus
inhibit
stress
granul
format
despit
caus
global
translat
suppress
host
mrna
suggest
hypothesi
stress
granul
may
antivir
role
cell
howev
mani
fundament
properti
biolog
function
stress
granul
unknown
gain
insight
biolog
role
stress
granul
stress
respons
regul
host
cell
gene
express
appli
nascent
chain
track
investig
behavior
individu
mrna
molecul
stress
simultan
monitor
mrna
translat
local
human
cell
examin
relationship
mrna
translat
stress
granul
format
reveal
mrna
accumul
stress
granul
nontransl
rare
instanc
mrna
associ
nascent
chain
dynam
interact
stress
granul
observ
mrna
initi
translat
stabli
associ
stress
granul
furthermor
mrna
interact
stress
granul
transient
highli
stabl
manner
increas
mrna
length
stress
granul
pbodi
size
correspond
mrna
persist
within
mrnp
granul
result
impli
sequestr
mrna
within
stress
granul
stabl
state
novel
regulatori
step
dictat
mrna
local
function
stress
futur
studi
examin
impact
viral
rna
local
within
stress
granul
viral
gene
express
replic
human
anim
studi
perform
erin
mcnulti
prion
research
center
colorado
state
univers
fort
collin
co
usa
present
data
describ
bioassay
remain
gold
standard
detect
prion
infect
provid
tremend
insight
understand
prion
pathogenesi
transmiss
dynam
convent
prion
detect
method
ihc
western
blot
heavili
reli
upon
abil
detect
prpsc
deposit
tissu
prioninfect
host
fact
ihc
consid
gold
standard
diagnost
test
demonstr
prioninfect
recent
introduct
assay
employ
amplif
prion
seed
present
tissu
bodili
fluid
infect
host
spmca
rtquic
enhanc
abil
identifi
prion
earlier
phase
diseas
sampl
contain
minut
quantiti
prion
new
gener
amplif
assay
report
sensit
level
rival
bioassay
thu
varieti
methodolog
use
detect
prion
yet
date
cross
platform
comparison
assay
perform
compar
convent
ihc
amplif
assay
spmca
rtquic
determin
abil
detect
prion
brain
tissu
harvest
cwd
mous
dilut
bioassay
demonstr
convent
ihc
perform
well
detect
prpsc
deposit
across
dilut
seri
also
reveal
enhanc
detect
prion
seed
activ
brain
tissu
lower
end
dilut
seri
rtquic
use
readout
spmca
summari
provid
evid
new
gener
amplif
assay
enhanc
prion
detect
sensit
rigor
convent
assay
vitro
detect
methodolog
never
replac
bioassay
may
use
tool
augment
detect
allevi
time
cost
financi
anim
life
anim
bioassay
becom
tool
earli
diagnosi
human
anim
protein
misfold
disord
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
ami
v
nall
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
chronic
wast
diseas
cwd
studi
nativ
whitetail
deer
provid
uniqu
repositori
serial
collect
sampl
repositori
permit
opportun
evalu
intra
interhost
cwd
traffick
dissemin
transmiss
throughout
protract
diseas
cours
mathiason
lab
extend
previou
studi
examin
hematogen
prion
load
blood
collect
minut
day
week
month
post
exposur
employ
enhanc
amplif
methodolog
corrobor
previou
find
detect
amyloid
format
whole
blood
blood
cell
fraction
harvest
earli
minut
post
inocul
throughout
diseas
cours
peak
clinic
diseas
find
bring
prion
field
step
closer
character
hematogen
prion
role
spread
prion
diseas
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
kaitlyn
wagner
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
discuss
studi
aim
detect
differ
chronic
wast
diseas
strain
differ
state
across
continent
us
chronic
wast
diseas
cwd
fatal
prion
diseas
affect
freerang
captiv
cervid
cwd
initi
describ
captiv
mule
deer
late
sinc
initi
descript
cwd
identifi
state
canadian
provid
south
korea
norway
outbreak
cwd
caus
transport
infect
anim
endem
region
origin
cwd
epizoot
unclear
well
character
previou
studi
shown
two
distinct
strain
cwd
howev
continu
spread
unclear
origin
sever
outbreak
warrant
continu
surveil
character
strain
divers
addit
thorough
understand
prion
strain
divers
within
ongo
outbreak
lack
address
issu
analyz
cwdposit
tissu
michigan
colorado
elucid
strain
differ
within
differ
outbreak
preliminari
analys
indic
strain
differ
cwd
colorado
cwd
michigan
addit
differ
cwd
strain
sampl
michigan
indic
cwdposit
anim
mi
infect
singl
cwd
strain
studi
use
transgen
mous
bioassay
assess
strain
differ
strain
strain
assess
addit
state
ongo
result
investig
improv
understand
prion
strain
distribut
divers
evolut
well
provid
inform
may
prove
use
manag
strategi
anim
human
studi
perform
juli
moreno
lab
glenn
tell
colorado
state
univers
prion
research
center
depart
microbiolog
immunolog
patholog
fort
collin
co
usa
present
inform
transmiss
spongiform
encephalopathi
tse
infecti
neurodegen
diseas
caus
misfold
normal
prion
protein
prpc
prpsc
known
cellular
factor
essenti
prion
propag
prpc
howev
cell
even
express
prpc
resist
prion
diseas
therefor
addit
unidentifi
cellular
factor
regul
diseas
suscept
andor
pathogenesi
address
compar
transcriptom
use
rna
sequenc
rnaseq
cell
suscept
resist
r
prion
infect
cell
deriv
rabbit
kidney
epitheli
cell
engin
express
prp
deer
elk
sheep
two
mous
embryon
fibroblast
mef
cell
line
r
cell
line
deriv
parent
clone
indic
r
cell
suscept
differ
due
genet
chang
compar
versu
r
rnaseq
raw
count
five
cell
line
identifi
two
differenti
express
gene
use
deseq
normal
method
transcript
oxid
stressrel
gene
decreas
approxim
twofold
cell
transcript
vesicl
traffickingrel
gene
increas
approxim
cell
compar
r
cell
rnaseq
chang
verifi
use
realtim
pcr
protein
express
techniqu
hypothes
candid
gene
suscept
factor
critic
propag
prion
shown
involv
vesicl
traffick
highli
express
brain
involv
recycl
selenocystein
sec
need
synthes
selenoprotein
mani
import
regul
cellular
redox
homeostasi
current
undergo
analysi
determin
role
oxid
stress
pathway
propag
infecti
prion
r
cell
use
marker
reactiv
oxygen
speci
ro
determin
level
selenoprotein
known
involv
redox
oxid
stress
pathway
lastli
determin
modul
level
alter
prion
propag
util
gene
edit
techniqu
remov
function
gene
express
construct
increas
level
r
cell
modul
gene
combin
cervid
prion
cell
assay
cpca
allow
determin
andor
critic
cellular
factor
prion
propag
anim
human
studi
perform
ryan
fahi
biofronti
institut
depart
molecular
cellular
development
biolog
univers
colorado
boulder
co
usa
explor
merit
implement
target
nextgener
sequenc
pipelin
use
illuminamiseq
platform
instead
tradit
sanger
sequenc
examin
popul
host
immun
factor
histor
sanger
sequenc
gold
standard
accur
sequenc
individu
gene
identifi
mutat
genet
materi
howev
sanger
cost
effect
sequenc
larg
number
sampl
unabl
perform
parallel
investig
multipl
target
region
target
nextgener
sequenc
abl
produc
larg
amount
data
multipl
target
region
high
throughput
applic
rel
cheapli
ideal
investig
populationlevel
divers
mani
context
howev
nextgener
sequenc
systemat
bias
result
base
miscal
erron
read
align
region
low
complex
compar
two
strategi
gather
consensu
sequenc
gene
night
monkey
aotu
nancymaa
sanger
illumnia
miseq
platform
highlight
improv
sensit
illumina
identifi
snp
variant
miss
sanger
sequenc
due
allelespecif
express
bia
time
show
improv
sensit
illumina
problem
deal
repetit
paralog
gene
famili
result
underscor
import
util
multipl
platform
test
develop
nextgener
sequenc
pipelin
minim
defici
target
nextgener
sequenc
capit
strength
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
colorado
boulder
